Dr. Marc A. Rovito, MD
- Medicare services, 2024
- 485
- Medicare patients, 2024
- 254
- Part D claims, 2024
- 1,194
- Publications
- 1
- Clinical trials
- 10
- Practice address
- 2500 Bernville Road, Reading, PA 19605
- Practice phone
- Call (610) 378-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Rovito's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Marc A. Rovito is a hematologist and oncologist in Reading, Pennsylvania
Dr. Rovito practices at Penn State Health St. Joseph Medical Center in Reading, Pennsylvania, part of Penn State.
Dr. Rovito's NPI, 1689768319, was assigned on October 3, 2006. Dr. Rovito graduated from Medical College of Pennsylvania in 1993. Dr. Rovito holds Pennsylvania license MD042375L.
- NPI
- 1689768319NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4284827221
- NPI enumeration date
- October 3, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (610) 378-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 59
- Medical school graduation
- 1993
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Marc A. Rovito practices at Penn State Health St. Joseph Medical Center in Reading, Pennsylvania
Dr. Rovito's primary practice is Penn State Health St. Joseph Medical Center, at 2500 Bernville Road, Reading, PA 19605 in Berks County. The practice phone is (610) 378-2000.
- Penn State Health St. Joseph Medical Center2500 Bernville Road, Reading, PA 19605 · Berks CountyPhone(610) 378-2000
Source: Dmand AI Affiliation Data
Dr. Marc A. Rovito is affiliated with 6 sites of care and 5 medical groups
Dr. Rovito's primary practice is Penn State Health St. Joseph Medical Center in Reading, Pennsylvania, part of Penn State. Dr. Rovito is also affiliated with Reading Hospital. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Rovito to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Marc A. Rovito's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rovito practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Penn State Health St. Joseph Medical Center | Available with a free account |
| +5 more sites and 4 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Penn State and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Marc A. Rovito is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Rovito's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Rovito is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Rovito
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Marc A. Rovito billed Medicare for 485 services in 2024
CMS data shows 485 Medicare services from Dr. Rovito across 4 procedure codes in 2024, all of them office visits, for 254 Medicare patients. Medicare paid $33,522 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Rovito's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4632024: 4855%
Dr. Rovito compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Rovito
- Pennsylvania median
- Medicare services
- 485vs 65426% below
- Medicare patients
- 254vs 22712% above
- Part D claims
- 971vs 3932.5 times
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Rovito's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rovito?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rovito and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Marc A. Rovito treated 254 Medicare patients in 2024, average age 73
CMS counts 254 Medicare patients who saw Dr. Rovito in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rovito's median patient age at 72, with 64% women.
Dr. Rovito's Medicare patients by age, 2024
Dr. Rovito's Medicare patients by sex, 2024
- Women16264%
- Men9236%
Chronic conditions among Dr. Rovito's Medicare patients, 2024
- High cholesterol75%
- High blood pressure74%
- Cancer60%
- Arthritis51%
- Diabetes30%
- Anxiety25%
- Mood disorders25%
- Chronic kidney disease24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rovito's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women64%
- Men36%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Marc A. Rovito wrote 1,194 Medicare Part D claims in 2024
In 2024, Dr. Rovito wrote 1,194 Medicare Part D claims for 267 patients. 87% of them were for generic drugs. CMS names the drug for 971 of them, across 27 drugs with 11 or more claims each, at $1,747,233 in total drug cost. In 2023, CMS named 908 claims across 26 drugs.
Dr. Rovito's Part D claims by kind of drug, 2024
- Generic1,044 claims87%
- Brand-name150 claims13%
Dr. Rovito's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rovito's Part D claims, 2024
- Opioids4%49 of 1,194 claims
- Antibiotics2%19 of 1,194 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9082024: 9717%
Drugs named by CMS: 27 in 2024, 26 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Marc A. Rovito scored 79 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Rovito for performance year 2024, reported as part of a group. Dr. Rovito accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Rovito's MIPS scores, performance year 2024
- 79of 100Final score
- 56.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 75of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Marc A. Rovito has 1 publication on record
Dmand AI links 1 paper to Dr. Rovito. Dr. Rovito's most frequent co-author is Jenia Jenab-Wolcott, MD.
Dr. Rovito's most frequent co-authors
Recent publications by Dr. Rovito
See who Dr. Rovito researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rovito works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Marc A. Rovito has worked on 10 clinical trials
Dmand AI links Dr. Rovito to 10 clinical trials, 5 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Adenocarcinoma, Bronchiolo-Alveolar. National Cancer Institute (NCI) sponsors the most, 8.
Clinical trials with Dr. Rovito by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 2Phase 2/3: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Rovito's trials
- Carcinoma, Bronchogenic
- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma, Bronchiolo-Alveolar
- Breast Neoplasms
- Carcinoma, Intraductal, Noninfiltrating
Investigators on the most trials with Dr. Rovito
- Firas Benyamine Badin, MD6 shared trials
- James Mitchell Granfortuna, MD6 shared trials
- Brian G. Vikstrom, MD6 shared trials
Recent clinical trials with Dr. Rovito
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Marc A. Rovito received $1,903 in industry payments from 2016 to 2024
CMS Open Payments shows 73 general payments to Dr. Rovito from 25 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 70% of the total. Sirtex Medical Inc paid the most, $380.
General payments to Dr. Rovito by program year, 2016 to 2024
General payments to Dr. Rovito by kind, 2016 to 2024
- Food and beverage$1,33570%
- Education$56730%
Companies that paid Dr. Rovito the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Marc A. Rovito graduated from Medical College of Pennsylvania
Dr. Rovito graduated from Medical College of Pennsylvania in 1993.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Marc A. Rovito's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Marc A. Rovito
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Marc A. Rovito's NPI number?
Dr. Marc A. Rovito's NPI number is 1689768319. It was assigned on October 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Marc A. Rovito?
Dr. Marc A. Rovito is a hematologist and oncologist in Reading, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Marc A. Rovito practice?
Dr. Rovito practices at 2500 Bernville Road, Reading, PA 19605. Dr. Rovito's primary practice is Penn State Health St. Joseph Medical Center in Reading, Pennsylvania, part of Penn State. Dmand AI also links Dr. Rovito to 3 hospitals, 4 medical groups and 1 group practice or clinic.
What is Dr. Marc A. Rovito's office phone number?
The practice phone on file for Dr. Rovito is (610) 378-2000.
What is Dr. Marc A. Rovito's medical license number?
Dr. Rovito holds Pennsylvania license MD042375L.
Which hospitals is Dr. Marc A. Rovito affiliated with?
Dr. Rovito practices at Penn State Health St. Joseph Medical Center in Reading, Pennsylvania. Dr. Rovito is also affiliated with Reading Hospital. Dmand AI links Dr. Rovito to 3 more hospitals.
What medical group is Dr. Marc A. Rovito part of?
Dr. Rovito is linked to Penn State Health Milton S. Hershey Medical Center. Dmand AI links Dr. Rovito to 4 more medical groups.
Does Dr. Marc A. Rovito accept Medicare?
Yes. CMS data shows Dr. Rovito billed Medicare for 485 services in 2024, and Dr. Rovito accepts Medicare assignment.
What is Dr. Marc A. Rovito's MIPS score?
Dr. Rovito's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.
How many Medicare patients does Dr. Marc A. Rovito see?
CMS counts 254 Medicare patients who saw Dr. Rovito in 2024, with an average age of 73.
Show 7 more questionsShow fewer questions
What services does Dr. Marc A. Rovito bill to Medicare?
In 2024, Dr. Rovito's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, new patient (99205).
Where did Dr. Marc A. Rovito go to medical school?
Dr. Rovito graduated from Medical College of Pennsylvania in 1993.
What drugs does Dr. Marc A. Rovito prescribe most?
In 2024 Medicare Part D data, Dr. Rovito's most prescribed drugs by claims were Letrozole, Prochlorperazine Maleate and Exemestane.
Has Dr. Marc A. Rovito received payments from drug or device companies?
CMS Open Payments shows $1,903 in general payments to Dr. Rovito from 25 companies from 2016 to 2024. The largest total came from Sirtex Medical Inc.
How long has Dr. Marc A. Rovito been practicing?
Dr. Rovito graduated from medical school in 1993, 33 years ago.
Does Dr. Marc A. Rovito do research?
Dmand AI links 1 publication to Dr. Rovito. Dr. Rovito has worked on 10 clinical trials.
Who does Dr. Marc A. Rovito publish with?
Dr. Rovito's most frequent co-authors are Jenia Jenab-Wolcott, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card